Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02311374 · ClinicalTrials.gov registry record · Early Phase 1
Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness
A Early Phase 1 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
NCT02311374 is a Early Phase 1 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 40 participants.
The verdict
NCT02311374, a Early Phase 1 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
Background: \- The glymphatic system helps keep harmful waste from building up in the brain. Researchers think it is more active in people during sleep than while awake. They want to study the glymphatic system using magnetic resonance imaging (MRI). Objective: \- To see if there are differences in the way waste is removed from the brain while a person is sleeping versus awake. Eligibility: \- Healthy people age 18-60. Design: * This study is in 2 parts. * For the technical part (discontinued), participants will be screened with medical history and physical exam. They will have urine and breath alcohol tests. * Participants will have 2 MRI scans. Before the scans, they will have urine and breath alcohol tests, and complete a questionnaire. * For MRI, participants will lie on a table that slides in and out of a metal cylinder. A device will be placed over their head. They will lie still for up to 20 minutes at a time. They may be asked to stay awake or fall asleep for up to 2 hours at a time. * For the research part, participants will be screened with medical history and physical exam. They will have urine and breath alcohol tests. For 1 week they will wear a device that monitors their activity and sleep. * Participants will stay at NIH overnight. They will give a blood sample, have urine and breath alcohol tests, and complete a questionnaire. * Participants will take memory, concentration, and thinking tests. * Participants will have 3 MRI scans. An electroencephalography machine will record their brain activity. Electrodes will be placed on their scalp.
Interventions
- OTHER Brain connectivity and physiology
- OTHER Brain Wave
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-07-28 |
| Est. Completion | 2018-05-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02311374
The ClinicalTrials.gov registry entry for NCT02311374 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brain connectivity and physiology is the first listed.
NCT02311374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02311374 about?
NCT02311374 is a clinical study titled "Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness". Background: \- The glymphatic system helps keep harmful waste from building up in the brain. Researchers think it is more active in people during sleep than while awake. They want to study the glymphatic system using magnetic resonance imaging (MRI). Objective: \- To see if there are differences ...
What is the current status of trial NCT02311374?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2015-07-28. Estimated completion is 2018-05-11.
What interventions are being tested in trial NCT02311374?
The interventions under investigation include: Brain connectivity and physiology (OTHER), Brain Wave (OTHER).
Who is sponsoring clinical trial NCT02311374?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.